(MedPage Today) — Clot-dissolving tenecteplase (TNKase) proved no better than aspirin for vision recovery after acute central retinal artery occlusion (CRAO), a multicenter randomized trial showed.
IV administration of the thrombolytic agent…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/119656
Author :
Publish date : 2026-01-29 22:43:00
Copyright for syndicated content belongs to the linked Source.
